Tuesday, June 09, 2020 4:12:25 PM
Wheres the sample? We've been told countless times a sample was needed. Where's the PR illustrating a usable sample batch was created? As far as my DD takes me, I've yet to see a usable batch. I know Lonza supposedly tried, but cliff notes say it failed. Plus sbfm wouldn't pay the 667,000 for another try......Lonza is about as good as it gets. If they actually tried. Again, I don't believe anything this place says.....they couldn't. So what the hell as they using on these supposed mice trials..?
https://www.biospace.com/article/releases/sunshine-biopharma-inc-to-receive-this-week-a-sample-from-the-adva-27a-manufacturing-currently-underway-at-lonza-inc-in-switzerland-/?keywords=Partner
Phase I study of Adva 27a for use in patients with multidrug-resistant breast cancer
Status: Planning
https://adisinsight.springer.com/trials/700060232
Lol, no one knows....like most scams. Never know, or always soon. Coming....next....ya ya.
All IMO.
Love the articles by one of the directors, and Dr. GILL FROM BInghamton University. I'm sure that's accurate. But again, paper is one thing aka. Hypothesis, actual product from hypothesis is a huge step. One that many cannot produce.
https://www.biospace.com/article/releases/sunshine-biopharma-inc-to-receive-this-week-a-sample-from-the-adva-27a-manufacturing-currently-underway-at-lonza-inc-in-switzerland-/?keywords=Partner
Phase I study of Adva 27a for use in patients with multidrug-resistant breast cancer
Status: Planning
https://adisinsight.springer.com/trials/700060232
Lol, no one knows....like most scams. Never know, or always soon. Coming....next....ya ya.
All IMO.
Love the articles by one of the directors, and Dr. GILL FROM BInghamton University. I'm sure that's accurate. But again, paper is one thing aka. Hypothesis, actual product from hypothesis is a huge step. One that many cannot produce.
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
